Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Cosinuke Insider Profile

4 Followers

Robert Cosinuke, former SVP & CMO at Athenahealth, holds 40.32K shares in Athenahealth (Ticker: ~ATHN). Most recently, Robert Cosinuke Sold 1,211 shares of Athenahealth on Oct 27, 2015 for an estimated value of $192.57K.

Robert Cosinuke's Trading History

~ATHN
Athenahealth
Oct 27, 2015―Informative Sell192.57K$5.44M
~ATHN
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 27, 2015Informative Sell$192.57K1,211$159.02+31.90%
Jun 04, 2015Uninformative Sell$28.98K250$115.91―
May 06, 2015Uninformative Sell$684.12K6,000$114.02―
Apr 08, 2015Uninformative Sell$715.56K6,000$119.26―
Apr 03, 2015Uninformative Sell$174.74K1,471$118.79―

You May Also Like

Robert Cosinuke insider profile FAQ

What is the percentage of profitable transactions made by Robert Cosinuke?
The percentage of profitable transactions made by Robert Cosinuke is 50%.
What is the average return per transaction made by Robert Cosinuke?
The average return per transaction made by Robert Cosinuke is 12.90%.
What stocks does Robert Cosinuke hold?
Robert Cosinuke holds: ~ATHN stocks.
What was Robert Cosinuke’s latest transaction?
Robert Cosinuke’s latest transaction was an Informative Sell of $192.57K.
What was Robert Cosinuke's most profitable transaction?
Robert Cosinuke’s most profitable transaction was an Informative Sell of ~ATHN stock on October 27, 2015. The return on the trade was 31.90%.
What is Robert Cosinuke's role in Athenahealth?
Robert Cosinuke's role in Athenahealth is SVP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.